Company Analysis
Sign in

Intensity Therapeutics, Inc. (INTS)

Nasdaq: INTS · Biological Products, (No Diagnostic Substances) · Shelton, CT · filing with the SEC since 2013
Full chart Alerts Compare
Grade4.6
◀ Past 3.3● Present 3.6▶ Future 6.3
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Intensity Therapeutics, Inc.’s names, not what it holds today.

Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
5
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'14'16'17'21'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Intensity Therapeutics, Inc. its own name
US, as the owner printed on each patent
4 granted
1 published
Intensity Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
4 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 16, 202512,496,345Method of treating cancerPharmaceuticalsIntensity Therapeutics, Inc.
Jan 12, 202110,888,618Method of treating cancerPharmaceuticalsIntensity Therapeutics, Inc.
May 2, 20179,636,406Method of treating cancerPharmaceuticalsIntensity Therapeutics, Inc.
May 31, 20169,351,997Method of treating cancerPharmaceuticalsIntensity Therapeutics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 26, 20232023/0338251METHOD OF TREATING CANCERPharmaceuticalsIntensity Therapeutics, Inc. · patent 12,496,345 granted from it
Mar 18, 20212021/0077627METHOD OF TREATING CANCERPharmaceuticalsIntensity Therapeutics, Inc.
Jun 15, 20172017/0165369METHOD OF TREATING CANCERPharmaceuticalsIntensity Therapeutics, Inc. · patent 10,888,618 granted from it
Jun 16, 20162016/0166697METHOD OF TREATING CANCERPharmaceuticalsIntensity Therapeutics, Inc. · patent 9,636,406 granted from it
Sep 4, 20142014/0248211METHOD OF TREATING CANCERPharmaceuticalsIntensity Therapeutics, Inc. · patent 9,351,997 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton INTS · research, not advice